Alpine Woods Capital Investors, LLC Sarepta Therapeutics, Inc. Transaction History

Alpine Woods Capital Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$76.53 - $135.58 $229,590 - $406,740	-3,000 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$72.81 - $156.91 $7,281 - $15,691	-100 Reduced 3.23%	3,000 $226,000
Q2 2019 Aug 05, 2019	BUY	$112.21 - $151.95 $347,851 - $471,044	3,100 New	3,100 $471,000
Q4 2018 Feb 13, 2019	SELL	$97.32 - $148.76 $214,590 - $328,015	-2,205 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$115.31 - $161.51 $254,258 - $356,129	2,205 New	2,205 $356,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.